FDA Commissioner's Drug Review Plan Sparks Alarm | Legal Questions Swirl Around FDA’s New Expedited Drug Program | FDA Cuts Threaten Drug Safety and Public Health Oversight | FDA Commissioner's Drug Review Plan Sparks Alarm | Legal Questions Swirl Around FDA’s New Expedited Drug Program | FDA Cuts Threaten Drug Safety and Public Health Oversight
An expedited drug review program initiated by the FDA commissioner is generating internal apprehension due to concerns regarding potential conflicts with established legal, ethical, and scientific benchmarks. The program aims to accelerate...
Legal questions swirl around FDA's new expedited drug program, including who should sign off
The FDA’s expedited drug review program, championed by the previous administration, faces scrutiny over legal and ethical concerns. This initiative, designed to fast-track the approval of certain medications, has raised questions about the...
Some drugmakers quietly concerned about legal risk with speedy FDA review program
Recent cuts at the Food and Drug Administration (FDA) are raising concerns about the agency's ability to ensure the safety of medications, particularly those manufactured in foreign factories. These reductions in staff and resources could c...